FLDM
Fluidigm Corp
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
Market Cap: 288 Million
Primary Exchange: NASDAQ
Website: www.fluidigm.com
Shares Outstanding: 76.5 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.3098460717904252
Sector: Manufacturing
Industry: Analytical Laboratory Instrument Manufacturing
Ethical Flags
Longest drawdown: 2317 trading days
From: 2014-03-05 To: 2022-04-04
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|